Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03657693

MRI in BPD Subjects

MRI for Quantitative Measurement of Pulmonary Growth and Development in Term and Extremely Pre-Term Babies in the BPD Center of Excellence

Status
Recruiting
Phase
Study type
Observational
Enrollment
160 (estimated)
Sponsor
Children's Hospital Medical Center, Cincinnati · Academic / Other
Sex
All
Age
4 Months
Healthy volunteers
Accepted

Summary

The investigators are wanting to learn more about early development of the lungs and to help them better understand prematurity and the development of a breathing disorder call BPD (Bronchopulmonary Dysplasia)

Detailed description

This is an observational case study involving up to three MRI visits. The first MRI will be complete after the infant's clinical initial evaluation. The second image will be obtained approximately 1 month later and the third MRI will be complete prior to discharge. Infants will be imaged at various ages, based up their initial evaluation. The investigators will collect urine and obtain clinically collected remnant blood around time of MRI, tracheal/endotracheal aspirate at time of the MRI when available and BAL samples as clinically available. MRI findings will be correlated with laboratory findings and outcomes from the medical record, and a research database will be built for the data. The investigators will also obtain a one-time MRI visit in non-BPD NICU patients to acquire data related to normal vasculature and pulmonary alveolar development. Sub-study 1: Inpatient polysomnography Patients with the same inclusion/exclusion criteria as reported below will be approached for a brief inpatient polysomnogram. The population will include patients with and without BPD. The polysomnography (PSG) will be performed in the NICU within 1 week from the MRI that is obtained prior to discharge.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNICU MRIMRI device that is not FDA approved.
DIAGNOSTIC_TESTPolysomnographyPolysomnography to better determine obstruction index in the airway.

Timeline

Start date
2018-05-04
Primary completion
2028-12-31
Completion
2030-12-31
First posted
2018-09-05
Last updated
2026-01-07

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03657693. Inclusion in this directory is not an endorsement.